As of 2025-10-24, the Intrinsic Value of Cogent Biosciences Inc (COGT) is -12.31 USD. This COGT valuation is based on the model Peter Lynch Fair Value. With the current market price of 14.84 USD, the upside of Cogent Biosciences Inc is -182.93%.
Based on its market price of 14.84 USD and our intrinsic valuation, Cogent Biosciences Inc (COGT) is overvalued by 182.93%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.31 - -12.31 | -12.31 | -182.93% |
| P/E | (142.95) - (142.95) | (142.95) | -1063.3% |
| DDM - Stable | (17.15) - (60.80) | (38.97) | -362.6% |
| DDM - Multi | (2.86) - (7.99) | (4.23) | -128.5% |
| Market Cap (mil) | 2,073.15 |
| Beta | 1.18 |
| Outstanding shares (mil) | 139.70 |
| Enterprise Value (mil) | 2,073.15 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.66% |
| Cost of Debt | 5.00% |
| WACC | 6.66% |